CMS announces payment adjustments for EHR Incentive Program in FY2017

Hospitals that couldn’t show meaningful use of certified electronic health record (EHR) technology in their 2015 reporting will have their payments reduced by 75 percent in the next fiscal year, CMS announced.

The reduction would come from the hospital’s Inpatient Prospective Payment System (IPPS) rate. The adjustments have risen over the past several years, starting with a 25 percent decrease for FY2015 (for the 2013 reporting period) and then a 50 percent decrease for FY2016 (for the 2014 reporting period). The adjustment will stay at 75 percent past 2017.

The more than 4,800 hospitals eligible for the EHR Incentive Program can apply for a hardship exemption, based on factors like lack of broadband service or problems with their EHR vendor, but hospitals had to apply for an exemption by April 1.

Most hospitals won’t need an exemption or a payment adjustment, as CMS said 98 percent of eligible hospitals and critical access hospitals successfully demonstrated meaningful use “at either Stage 1 or Stage 2,” leaving around 100 hospitals who failed to meet those standards.

The agency’s fact sheet pointed out hospitals have to demonstrate meaningful every year to avoid reductions to payments.

“For example, an eligible hospital that demonstrates meaningful use for the first time in 2013 will avoid the payment adjustment in FY2015, but will need to demonstrate meaningful use again in 2015 in order to avoid the payment adjustment in FY2017,” CMS said. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup